A Study to Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone®

Completed · Phase 4

Conditions studied: Multiple Sclerosis

In brief

This study is designed to compare skin reactions with or without the use of warm compress prior to performing a Copaxone® injection.

Key facts

Study ID

NCT00239993

Run by

Teva Neuroscience, Inc.

People needed

50

Starts

2005-08-01

Expected to finish

2006-02-01

Last updated by the study team

2017-02-06

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or Female, 18 years or older, with a diagnosis of RRMS
• Willing and able to complete all procedures and evaluations related to the study.
• Willing to provide Informed Consent

You may not qualify if…

• Taking any other immunomodulatory therapy in conjunction with Copaxone®.
• Has a significant medical illness other than MS which may interfere with the assessment of endpoints or the subject's participation in the trial for the full duration of the study.
• Any situation which the investigator or nurse feels may interfere with participation in the study.
• Pregnant, or trying to become pregnant, or breast feeding during the study.
• Previously participated in this study.

Where it is running

• Fullerton Neurology & Headache Center — Fullerton, California, United States
• Neurological Center of South Florida — Miami, Florida, United States
• Springfield Neurology Associates — Springfield, Massachusetts, United States
• Multiple Sclerosis Care Center — Brooklyn, New York, United States
• Advanced Neurosciences Institute — Nashville, Tennessee, United States
• Virginia Beach Neurology — Virginia Beach, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.